Jin-Hua Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jin-Hua Ren has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Chu-Ming Sheng
Department of Materials Science, National Engineering Laboratory for TFT-LCD Materials and Technologies, Fudan University, Shanghai 200433, PR China
1 shared publicationCongmeng Lin
Department of Hematology Zhangzhou Municipal Hospital of Fujian Province Zhangzhou Fujian P. R. China
1 shared publicationJianda Hu
Department of Hematology Fujian Institute of Hematology Fujian Provincial Key Laboratory of Hematology Fujian Medical University Union Hospital Fuzhou Fujian P. R. China
1 shared publication- Jie Shen
TNO/Holst Centre, High Tech Campus 31, 5656 AE Eindhoven, The Netherlands
1 shared publication - Jingjing Shao
Institut für Chemie und Biochemie, Freie Universität Berlin, Arnimallee 22, 14195 Berlin, Germany
1 shared publication Jingjing Xu
Department of Hematology Fujian Institute of Hematology Fujian Provincial Key Laboratory of Hematology Fujian Medical University Union Hospital Fuzhou Fujian P. R. China
1 shared publication
Latest Publications
- 21 November 2023
- Published by Wiley in Clinical Transplantation
- Vol. 38 (1) , e15195
When is the best time and grade to start ruxolitinib in corticosteroid‐refractory acute graft‐versus‐host‐disease: A multi‐center research
Objective: Ruxolitinib was recently approved to treat corticosteroid‐resistant acute graft‐versus‐host disease (GvHD). However, it is unknown as to whether starting ruxolitinib at a lower versus higher acute GvHD grade or earlier versus later affected outcomes. This study identified the impact of starting acute GvHD grade and start time after declaring corticosteroid resistance and the effect on complete and overall response rates to ruxolitinib therapy.Methods: Retrospective, observational multi‐center study. We divided cohorts into starting ruxolitinib ≤ 7 days (N = 45) versus at > 7 days after declaring corticosteroid resistance (N = 24).Results: In ≤ 7 days cohort complete response (CR) rates at day 28 were 69% (54, 81%) versus 25% (11, 47%; p = .001) in > 7 days cohort, and overall response (OR) rates were 91% (78, 96%) versus 80% (48, 92%; p = .25).Conclusions: Our data suggest that starting ruxolitinib in ≤ 7 days of declaring corticosteroid failure regardless of G vHD grade improves complete response rate but not OR rates. Starting ruxolitinib at grade I and within 7 days may get a more significant response.
- 21 November 2023
- Published by Wiley in Clinical Transplantation
- Vol. 38 (1) , e15195
When is the best time and grade to start ruxolitinib in corticosteroid‐refractory acute graft‐versus‐host‐disease: A multi‐center research
Objective: Ruxolitinib was recently approved to treat corticosteroid‐resistant acute graft‐versus‐host disease (GvHD). However, it is unknown as to whether starting ruxolitinib at a lower versus higher acute GvHD grade or earlier versus later affected outcomes. This study identified the impact of starting acute GvHD grade and start time after declaring corticosteroid resistance and the effect on complete and overall response rates to ruxolitinib therapy.Methods: Retrospective, observational multi‐center study. We divided cohorts into starting ruxolitinib ≤ 7 days (N = 45) versus at > 7 days after declaring corticosteroid resistance (N = 24).Results: In ≤ 7 days cohort complete response (CR) rates at day 28 were 69% (54, 81%) versus 25% (11, 47%; p = .001) in > 7 days cohort, and overall response (OR) rates were 91% (78, 96%) versus 80% (48, 92%; p = .25).Conclusions: Our data suggest that starting ruxolitinib in ≤ 7 days of declaring corticosteroid failure regardless of G vHD grade improves complete response rate but not OR rates. Starting ruxolitinib at grade I and within 7 days may get a more significant response.
- 1 November 2019
- Published by Elsevier in Applied Surface Science
- Vol. 493, 63-69
Preparation of rare-earth thulium doped tin-oxide thin films and their applications in thin film transistors
- 1 November 2019
- Published by Elsevier in Applied Surface Science
- Vol. 493, 63-69
Preparation of rare-earth thulium doped tin-oxide thin films and their applications in thin film transistors